vs

Side-by-side financial comparison of Mueller Water Products, Inc. (MWA) and Ultragenyx Pharmaceutical Inc. (RARE). Click either name above to swap in a different company.

Mueller Water Products, Inc. is the larger business by last-quarter revenue ($318.2M vs $207.3M, roughly 1.5× Ultragenyx Pharmaceutical Inc.). Mueller Water Products, Inc. runs the higher net margin — 13.6% vs -62.0%, a 75.6% gap on every dollar of revenue. On growth, Ultragenyx Pharmaceutical Inc. posted the faster year-over-year revenue change (25.9% vs 4.6%). Mueller Water Products, Inc. produced more free cash flow last quarter ($44.0M vs $-100.8M). Over the past eight quarters, Ultragenyx Pharmaceutical Inc.'s revenue compounded faster (38.0% CAGR vs -5.1%).

Mueller Water Products, Inc. (MWP) is a publicly traded company headquartered in Atlanta, Georgia. It is one of the largest manufacturers and distributors of fire hydrants, gate valves, and other water infrastructure products in North America. MWP is made up of two business units—Mueller Co. and Mueller Technologies—that oversee more than a dozen brands and affiliates, including Echologics and Mueller Systems.

Ultragenyx Pharmaceutical Inc. is an American biopharmaceutical company involved in the research and development of novel products for treatment of rare and ultra-rare genetic diseases for which there are typically no approved treatments and high unmet medical need. The company works with multiple drug modalities including biologics, small molecule, gene therapies, and ASO and mRNAs in the disease categories of bone, endocrine, metabolic, muscle and CNS diseases.

MWA vs RARE — Head-to-Head

Bigger by revenue
MWA
MWA
1.5× larger
MWA
$318.2M
$207.3M
RARE
Growing faster (revenue YoY)
RARE
RARE
+21.3% gap
RARE
25.9%
4.6%
MWA
Higher net margin
MWA
MWA
75.6% more per $
MWA
13.6%
-62.0%
RARE
More free cash flow
MWA
MWA
$144.8M more FCF
MWA
$44.0M
$-100.8M
RARE
Faster 2-yr revenue CAGR
RARE
RARE
Annualised
RARE
38.0%
-5.1%
MWA

Income Statement — Q1 FY2026 vs Q4 FY2025

Metric
MWA
MWA
RARE
RARE
Revenue
$318.2M
$207.3M
Net Profit
$43.2M
$-128.6M
Gross Margin
37.6%
Operating Margin
17.8%
-54.7%
Net Margin
13.6%
-62.0%
Revenue YoY
4.6%
25.9%
Net Profit YoY
22.4%
3.5%
EPS (diluted)
$0.27
$-1.28

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
MWA
MWA
RARE
RARE
Q4 25
$318.2M
$207.3M
Q3 25
$380.8M
$159.9M
Q2 25
$380.3M
$166.5M
Q1 25
$364.3M
$139.3M
Q4 24
$304.3M
$164.6M
Q3 24
$348.2M
$139.5M
Q2 24
$356.7M
$147.0M
Q1 24
$353.4M
$108.8M
Net Profit
MWA
MWA
RARE
RARE
Q4 25
$43.2M
$-128.6M
Q3 25
$52.6M
$-180.4M
Q2 25
$52.5M
$-115.0M
Q1 25
$51.3M
$-151.1M
Q4 24
$35.3M
$-133.2M
Q3 24
$10.0M
$-133.5M
Q2 24
$47.3M
$-131.6M
Q1 24
$44.3M
$-170.7M
Gross Margin
MWA
MWA
RARE
RARE
Q4 25
37.6%
Q3 25
36.8%
Q2 25
38.3%
Q1 25
35.1%
Q4 24
33.8%
Q3 24
31.8%
Q2 24
36.8%
Q1 24
36.9%
Operating Margin
MWA
MWA
RARE
RARE
Q4 25
17.8%
-54.7%
Q3 25
18.3%
-106.9%
Q2 25
19.4%
-64.8%
Q1 25
19.2%
-102.6%
Q4 24
15.6%
-74.3%
Q3 24
8.2%
-94.6%
Q2 24
18.8%
-79.1%
Q1 24
18.0%
-151.9%
Net Margin
MWA
MWA
RARE
RARE
Q4 25
13.6%
-62.0%
Q3 25
13.8%
-112.8%
Q2 25
13.8%
-69.0%
Q1 25
14.1%
-108.5%
Q4 24
11.6%
-80.9%
Q3 24
2.9%
-95.7%
Q2 24
13.3%
-89.5%
Q1 24
12.5%
-156.8%
EPS (diluted)
MWA
MWA
RARE
RARE
Q4 25
$0.27
$-1.28
Q3 25
$0.34
$-1.81
Q2 25
$0.33
$-1.17
Q1 25
$0.33
$-1.57
Q4 24
$0.22
$-1.34
Q3 24
$0.07
$-1.40
Q2 24
$0.30
$-1.52
Q1 24
$0.28
$-2.03

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
MWA
MWA
RARE
RARE
Cash + ST InvestmentsLiquidity on hand
$421.0M
Total DebtLower is stronger
Stockholders' EquityBook value
$1.0B
$-80.0M
Total Assets
$1.8B
$1.5B
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
MWA
MWA
RARE
RARE
Q4 25
$421.0M
Q3 25
$202.5M
Q2 25
$176.3M
Q1 25
$127.1M
Q4 24
$174.0M
Q3 24
$150.6M
Q2 24
$480.7M
Q1 24
$112.3M
Stockholders' Equity
MWA
MWA
RARE
RARE
Q4 25
$1.0B
$-80.0M
Q3 25
$981.7M
$9.2M
Q2 25
$929.0M
$151.3M
Q1 25
$873.6M
$144.2M
Q4 24
$834.1M
$255.0M
Q3 24
$810.1M
$346.8M
Q2 24
$791.6M
$432.4M
Q1 24
$754.5M
$140.3M
Total Assets
MWA
MWA
RARE
RARE
Q4 25
$1.8B
$1.5B
Q3 25
$1.8B
$1.2B
Q2 25
$1.7B
$1.3B
Q1 25
$1.7B
$1.3B
Q4 24
$1.6B
$1.5B
Q3 24
$1.6B
$1.5B
Q2 24
$1.6B
$1.6B
Q1 24
$1.5B
$1.3B

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
MWA
MWA
RARE
RARE
Operating Cash FlowLast quarter
$61.2M
$-99.8M
Free Cash FlowOCF − Capex
$44.0M
$-100.8M
FCF MarginFCF / Revenue
13.8%
-48.6%
Capex IntensityCapex / Revenue
5.4%
0.5%
Cash ConversionOCF / Net Profit
1.42×
TTM Free Cash FlowTrailing 4 quarters
$173.8M
$-472.0M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
MWA
MWA
RARE
RARE
Q4 25
$61.2M
$-99.8M
Q3 25
$83.5M
$-91.4M
Q2 25
$67.4M
$-108.3M
Q1 25
$14.3M
$-166.5M
Q4 24
$54.1M
$-79.3M
Q3 24
$89.3M
$-67.0M
Q2 24
$87.3M
$-77.0M
Q1 24
$-5.7M
$-190.7M
Free Cash Flow
MWA
MWA
RARE
RARE
Q4 25
$44.0M
$-100.8M
Q3 25
$69.0M
$-92.7M
Q2 25
$55.7M
$-110.7M
Q1 25
$5.1M
$-167.8M
Q4 24
$42.2M
$-79.5M
Q3 24
$69.9M
$-68.6M
Q2 24
$75.1M
$-79.0M
Q1 24
$-15.8M
$-193.9M
FCF Margin
MWA
MWA
RARE
RARE
Q4 25
13.8%
-48.6%
Q3 25
18.1%
-58.0%
Q2 25
14.6%
-66.5%
Q1 25
1.4%
-120.5%
Q4 24
13.9%
-48.3%
Q3 24
20.1%
-49.2%
Q2 24
21.1%
-53.7%
Q1 24
-4.5%
-178.2%
Capex Intensity
MWA
MWA
RARE
RARE
Q4 25
5.4%
0.5%
Q3 25
3.8%
0.8%
Q2 25
3.1%
1.5%
Q1 25
2.5%
1.0%
Q4 24
3.9%
0.1%
Q3 24
5.6%
1.2%
Q2 24
3.4%
1.4%
Q1 24
2.9%
3.0%
Cash Conversion
MWA
MWA
RARE
RARE
Q4 25
1.42×
Q3 25
1.59×
Q2 25
1.28×
Q1 25
0.28×
Q4 24
1.53×
Q3 24
8.93×
Q2 24
1.85×
Q1 24
-0.13×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

MWA
MWA

Water Flow Solutions$173.0M54%
Water Management Solutions$145.2M46%

RARE
RARE

Royalty$105.6M51%
Products$101.7M49%

Related Comparisons